J7503 is a valid 2023 HCPCS Code that could be used to indicate Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg for reimbursement purposes.
J7503 belongs to Medical Care Type of Service and has been in effect since Jan 01, 2019.
Tacrol envarsus ex rel oral
J7503 code information
| HCPCS code: | J7503 |
| Description: | TACROLIMUS, EXTENDED RELEASE, (ENVARSUS XR), ORAL, 0.25 MG |
| Effective Date: | Jan 01, 2019 |
| Added Date: | Jan 01, 2016 |
| Termination Date: | HCPCS J7503 was terminated on Nov 30, -0001 |
| Pricing indicator: | 51 - DRUGS |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | D - SPECIAL COVERAGE INSTRUCTIONS APPLY |
| BETOS code: | O1E - OTHER DRUGS |
| Action code: | N - NO MAINTENANCE FOR THIS CODE |
| Type of Service: |
1 - MEDICAL CARE
G - IMMUNOSUPPRESSIVE DRUGS
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to J7503